Forecasting The Future: 4 Analyst Projections For GE HealthCare Techs

Analysts' ratings for GE HealthCare Techs (NASDAQ:GEHC) over the last quarter vary from bullish to bearish, as provided by 4 analysts.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

	Bullish	Somewhat Bullish	Indifferent	Somewhat Bearish	Bearish
Total Ratings	3	1	0	0	0
Last 30D	1	0	0	0	0
1M Ago	1	1	0	0	0
2M Ago	0	0	0	0	0
3M Ago	1	0	0	0	0

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $104.0, a high estimate of $110.00, and a low estimate of $100.00. Observing a 9.76% increase, the current average has risen from the previous average price target of $94.75.

Interpreting Analyst Ratings: A Closer Look

A clear picture of GE HealthCare Techs's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
David Roman	Goldman Sachs	Raises	Buy	$100.00	$85.00
Larry Biegelsen	Wells Fargo	Raises	Overweight	$103.00	$96.00
Joanne Wuensch	Citigroup	Raises	Buy	$110.00	$103.00
Matthew Taylor	Jefferies	Raises	Buy	$103.00	$95.00

Key Insights:

• Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to GE HealthCare Techs. This information offers a snapshot of how analysts perceive the current state of the company.
• Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of GE HealthCare Techs compared to the broader market.
• Price Targets: Analysts predict movements in price targets, offering estimates for GE HealthCare Techs's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of GE HealthCare Techs's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on GE HealthCare Techs analyst ratings.

Get to Know GE HealthCare Techs Better

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Unraveling the Financial Story of GE HealthCare Techs

Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.

Revenue Growth: Over the 3 months period, GE HealthCare Techs showcased positive performance, achieving a revenue growth rate of 2.17% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: GE HealthCare Techs's net margin is impressive, surpassing industry averages. With a net margin of 13.56%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 8.6%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): GE HealthCare Techs's ROA excels beyond industry benchmarks, reaching 2.15%. This signifies efficient management of assets and strong financial health.

Debt Management: GE HealthCare Techs's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.11, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

Analyst Ratings: Simplified

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.